- Home
- PRK vs CRNX Comparison
PRK vs CRNX Comparison
Compare PRK & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRK
- CRNX
- Stock Information
- Founded
- PRK 1908
- CRNX 2008
- Country
- PRK United States
- CRNX United States
- Employees
- PRK N/A
- CRNX N/A
- Industry
- PRK Major Banks
- CRNX Biotechnology: Pharmaceutical Preparations
- Sector
- PRK Finance
- CRNX Health Care
- Exchange
- PRK Nasdaq
- CRNX Nasdaq
- Market Cap
- PRK 2.6B
- CRNX 2.8B
- IPO Year
- PRK N/A
- CRNX 2018
- Fundamental
- Price
- PRK $158.82
- CRNX $30.16
- Analyst Decision
- PRK Hold
- CRNX Strong Buy
- Analyst Count
- PRK 1
- CRNX 10
- Target Price
- PRK $170.00
- CRNX $75.00
- AVG Volume (30 Days)
- PRK 54.8K
- CRNX 699.5K
- Earning Date
- PRK 07-21-2025
- CRNX 08-07-2025
- Dividend Yield
- PRK 2.99%
- CRNX N/A
- EPS Growth
- PRK 23.42
- CRNX N/A
- EPS
- PRK 9.75
- CRNX N/A
- Revenue
- PRK $515,788,000.00
- CRNX $760,000.00
- Revenue This Year
- PRK $7.96
- CRNX $402.12
- Revenue Next Year
- PRK $3.31
- CRNX $770.88
- P/E Ratio
- PRK $16.35
- CRNX N/A
- Revenue Growth
- PRK 10.66
- CRNX N/A
- 52 Week Low
- PRK $134.10
- CRNX $24.10
- 52 Week High
- PRK $207.99
- CRNX $62.53
- Technical
- Relative Strength Index (RSI)
- PRK 45.64
- CRNX 41.11
- Support Level
- PRK $156.68
- CRNX $32.05
- Resistance Level
- PRK $166.55
- CRNX $31.56
- Average True Range (ATR)
- PRK 2.53
- CRNX 1.08
- MACD
- PRK -0.81
- CRNX -0.18
- Stochastic Oscillator
- PRK 21.68
- CRNX 5.25
About PRK Park National Corporation
Park National Corp is a diversified financial services company based in Newark, Ohio, consisting of 11 community banking divisions with more than 100 offices in Ohio and Kentucky. Park National provides banking and other financial services to consumers and businesses.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.